Advertisement
Home 2015

Archives

The U.S. Food and Drug Administration announced new steps Thursday to improve the cleanliness of food manufacturing plants in the wake of a string of foodborne illness outbreaks.

FDA Announces New Steps to Improve Food Safety in U.S.

0
New rules focus on cleanliness of manufacturing facilities
A second death has been reported in a Salmonella outbreak that has been linked to contaminated cucumbers and caused 341 illnesses in 30 states

CDC: Second Death Reported in Salmonella Outbreak

0
Tainted cucumbers also linked to 341 illnesses in 30 states, CDC officials report
Two newly approved medications to treat high cholesterol are extremely overpriced compared to the health benefits they give to patients

ICER: New Cholesterol Drugs Highly Overpriced

0
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
The U.S. Preventive Services Task Force (USPSTF) recommends screening for major depressive disorder in adolescents

USPSTF Recommends Depression Screening for Teens

0
Screening advised for those aged 12-18; insufficient evidence to weigh benefits for younger children
The U.S. Food and Drug Administration has issued a warning that injectable skin-lightening products are potentially unsafe and ineffective.

FDA Issues Warning Regarding Injectable Skin Lighteners

0
Injectable products may contain unknown substances or contaminants
Almost a third of U.S. children with attention-deficit/hyperactivity disorder were diagnosed before the age of 6

One-Third of U.S. Children With ADHD Diagnosed Before Age 6

0
But researchers add that few valid tests exist to support diagnosis in children that young
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

0
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
The U.S. smoking rate continues to decline

CDC: Smoking Rate Falls to 15.2 Percent in the United States

0
Higher tobacco taxes, tough messages contributing to decline
Use of dipeptidyl peptidase-4 inhibitors in type 2 diabetes is tied to severe joint pain in some patients

FDA Warns of Joint Pain Tied to DPP-4 Inhibitors

0
Agency advises users with such symptoms to contact their doctor
The outcome of a recent case regarding the termination of physicians by an insurance company following a dispute over the necessity of medical services provided has serious implications for physicians and their patients

AMA: Ruling Makes It Easier for Insurers to Terminate Doctors

0
Court supported insurance company in termination of doctors after dispute over necessity of services